NEW YORK (360Dx) – First Light Diagnostics announced today it has closed an oversubscribed Series A-2 financing round that raised $8.25 million.

The financing will go toward continued development of its MultiPath technology to rapidly identify hospital infections and determine their antibiotic susceptibility. The company expects to commercialize the technology in early 2020, it said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.